[Remote] Regional Account Manager, Midwest at Moderna

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's Degree and a minimum of 10 years of experience in pharmaceutical or biotech account strategy and account management. Prior experience in vaccines, establishing and exceeding sales targets, working in a startup environment, and with complex Academic Medical Centers is highly preferred. Familiarity with capitated and risk-based providers and value-based care fundamentals is also desired.

Responsibilities

The Regional Account Manager will be responsible for developing and enhancing customer relationships with key vaccinators within their assigned territory, including Health Systems, State Awardees/VFC, FQHCs, and Physician Groups. They will develop expert knowledge of Moderna's vaccine portfolio and mRNA platform to expand vaccination rates and achieve sales targets. Key duties include developing strategic account plans, acting as the primary point of contact for the territory, analyzing sales trends, establishing and executing tactical initiatives, and representing Moderna at industry meetings.

Skills

Sales

Account Management

Customer Relationship Management

Vaccine Portfolio Knowledge

mRNA Platform Knowledge

Strategic Account Planning

Negotiation

Sales Trend Analysis

Business Development

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters

2010Year Founded

$5,925.5MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.

Possible removal from Nasdaq 100 Index could affect investor confidence.

Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.

The company integrates AI to optimize mRNA design and production processes.

Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.

The company is expanding mRNA applications to personalized cancer vaccines.

Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI

Try Jobo Free